Direct oral anticoagulant for the prevention of thrombosis in ambulatory patients with cancer: A systematic review and meta-analysis.

Ang LiNicole M KudererDavid A GarciaAlok A KhoranaPhilip S WellsMarc CarrierGary H Lyman

Published in: Journal of thrombosis and haemostasis : JTH (2019)

Low-dose DOAC reduces the rate of overall VTE in higher risk cancer patients starting systemic chemotherapy. It may reduce the rate of symptomatic VTE but increase the likelihood of bleeding.

Keyphrases

venous thromboembolism
direct oral anticoagulants
low dose
atrial fibrillation
blood pressure
pulmonary embolism
high dose
locally advanced